Glucose
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01914 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | non-syndromic esophageal malformation | KG + DL |
| 2 | primary hereditary glaucoma | KG + DL |
| 3 | open-angle glaucoma | KG + DL |
| 4 | esophageal disease | KG + DL |
| 5 | biotin metabolic disease | KG + DL |
| 6 | vitamin deficiency disorder | KG + DL |
| 7 | dermatitis | KG + DL |
| 8 | neonatal dermatomyositis | KG + DL |
| 9 | acrodermatitis chronica atrophicans | KG + DL |
| 10 | hydroa vacciniforme, familial | KG + DL |
| 11 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 12 | amyopathic dermatomyositis | KG + DL |
| 13 | acne keloid | KG + DL |
| 14 | non-severe combined immunodeficiency | KG + DL |
| 15 | sclerosing cholangitis | KG + DL |
| 16 | Immunoerythromyeloid hypoplasia | KG + DL |
| 17 | lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome | KG + DL |
| 18 | dry eye syndrome | KG + DL |
| 19 | T-B+ severe combined immunodeficiency due to CD45 deficiency | KG + DL |
| 20 | combined immunodeficiency due to ORAI1 deficiency | KG + DL |
| 21 | severe combined immunodeficiency (disease) | KG + DL |
| 22 | T-B+ severe combined immunodeficiency due to gamma chain deficiency | KG + DL |
| 23 | congenital combined immunodeficiency | KG + DL |
| 24 | open angle glaucoma | KG + DL |
| 25 | X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia | KG + DL |
| 26 | severe combined immunodeficiency due to LCK deficiency | KG + DL |
| 27 | drug-induced osteoporosis | KG + DL |
| 28 | atypical coarctation of aorta | KG + DL |
| 29 | Omenn syndrome | KG + DL |
| 30 | aortic malformation | KG + DL |
| 31 | T-B- severe combined immunodeficiency | KG + DL |
| 32 | combined immunodeficiency, X-linked | KG + DL |
| 33 | reticular dysgenesis | KG + DL |
| 34 | T-B+ severe combined immunodeficiency | KG + DL |
| 35 | combined immunodeficiency due to CD3gamma deficiency | KG + DL |
| 36 | mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency | KG + DL |
| 37 | complement deficiency | KG + DL |
| 38 | adenosine deaminase deficiency | KG + DL |
| 39 | cryptosporidiosis-chronic cholangitis-liver disease syndrome | KG + DL |
| 40 | congenital prothrombin deficiency | KG + DL |
| 41 | autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency | KG + DL |
| 42 | autosomal recessive lymphoproliferative disease | KG + DL |
| 43 | combined immunodeficiency due to ZAP70 deficiency | KG + DL |
| 44 | janus kinase-3 deficiency | KG + DL |
| 45 | CD4 deficiency | KG + DL |
| 46 | recombinase activating gene 1 deficiency | KG + DL |
| 47 | recombinase activating gene 2 deficiency | KG + DL |
| 48 | glaucoma 1, open angle | KG + DL |
| 49 | immunodeficiency 65, susceptibility to viral infections | KG + DL |
| 50 | immunodeficiency 11b with atopic dermatitis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.